Clinical implications of leukocyte infiltration at the choroid plexus in (neuro)inflammatory disorders. Issue 8 (August 2015)

• Record Type: Journal Article
• Authors: Demeestere, Delphine; Libert, Claude; Vandenbroucke, Roosmarijn E.
• Is Part Of: Drug discovery today. Volume 20:Issue 8(2015)
• Page Start: 928
• Page End: 941
• Publication Date: 2015-08
• Subjects: Drugs -- Design -- Periodicals; Drugs -- Research -- Periodicals; 615.1
• DOI: 10.1016/j.drudis.2015.05.003
• Languages: English
• ISSNs: 1359-6446

Abstract

<abstract abstract-type="author" id="abs0010"> <title> <x xml:space="preserve">Abstract</x> </title> <sec> <p id="spar0005">The choroid plexus (CP) is a highly vascularized organ located in the brain ventricles and contains a single epithelial cell layer forming the blood–cerebrospinal fluid barrier (BCSFB). This barrier is crucial for immune surveillance in health and is an underestimated gate for entry of immune cells during numerous inflammatory disorders. Several of these disorders are accompanied by disturbance of the BCSFB and increased leukocyte infiltration, which affects neuroinflammation. Understanding the mechanism of immune cell entry at the CP might lead to identification of new therapeutic targets. Here, we focus on current knowledge of leukocyte infiltration at the CP in inflammatory conditions and its therapeutic implications.</p> </sec> </abstract>